Our portfolio
Gavi / Serum Institute of India

Ensured LMIC access to COVID-19 vaccines

Gavi and the Serum Institute of India are accelerating the manufacture and delivery of up to 200 million doses of COVID-19 vaccines for low- and middle-income countries.
Website
  • Domain
    Healthcare Delivery
  • Investment type
    Debt
  • Status
    Active
  • Initial investment
    Private
  • Partnered in
    2020
  • Investment lead
    Natalie Revelle
  • Headquarters
    India
  • Program strategy
    COVID-19 Response
Portfolio news
New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle-income countries

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.